Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, September 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 194 articles:
HTML format


 

Single Articles

  1. LIAO Y, Li Q
    Profile of MeltPro(R) HPV test for human papillomavirus genotyping and pre-cervical cancer screening.
    Expert Rev Mol Diagn. 2019 Aug 29. doi: 10.1080/14737159.2019.1662299.
    Abstract    

    Abstract available

  2. HE Y, Rong Y, Chen H, Zhang Z, et al
    Impact of different b-value combinations on radiomics features of apparent diffusion coefficient in cervical cancer.
    Acta Radiol. 2019 Aug 29:284185119870157. doi: 10.1177/0284185119870157.
    Abstract    



  3. SEN P, Ghosal S, Hazra R, Arega S, et al
    Transcriptomic analyses of gene expression by CRISPR knockout of miR-214 in cervical cancer cells.
    Genomics. 2019 Aug 26. pii: S0888-7543(19)30413.
    Abstract    

    Abstract available

  4. TOMEN EA, Yohanna S, Obilom RE
    Awareness of Papanicolaou Smear and Visual Inspection with Acetic Acid as Screening Tools for Cervical Cancer among Women Attending the General Outpatient Clinic of a Tertiary Institution in North Central Nigeria.
    Niger Med J. 2019;60:76-79.
    Abstract    

    Abstract available

  5. WU KJ, Liu X, Wong SY, Zhou Y, et al
    Synthesis and Evaluation of Dibenzothiophene Analogues as Pin1 Inhibitors for Cervical Cancer Therapy.
    ACS Omega. 2019;4:9228-9234.
    Abstract    

    Abstract available

  6. CHEN T, Yang S, Xu J, Lu W, et al
    Transcriptome sequencing profiles of cervical cancer tissues and SiHa cells.
    Funct Integr Genomics. 2019 Aug 27. pii: 10.1007/s10142-019-00706.
    Abstract    

    Abstract available

  7. ZHEN S, Lu J, Liu YH, Chen W, et al
    Synergistic antitumor effect on cervical cancer by rational combination of PD1 blockade and CRISPR-Cas9-mediated HPV knockout.
    Cancer Gene Ther. 2019 Aug 27. pii: 10.1038/s41417-019-0131.
    Abstract    

    Abstract available

  8. ANNEDE P, Gouy S, Haie-Meder C, Morice P, et al
    [Place of radiotherapy and surgery in the treatment of cervical cancer patients].
    Cancer Radiother. 2019 Aug 24. pii: S1278-3218(19)30327.
    Abstract    

    Abstract available

  9. CALDERON-MORA J, Byrd TL, Alomari A, Salaiz R, et al
    Group Versus Individual Culturally Tailored and Theory-Based Education to Promote Cervical Cancer Screening Among the Underserved Hispanics: A Cluster Randomized Trial.
    Am J Health Promot. 2019 Aug 27:890117119871004. doi: 10.1177/0890117119871004.
    Abstract    

    Abstract available

  10. HU P, Zhou G, Zhang X, Song G, et al
    Long non-coding RNA Linc00483 accelerated tumorigenesis of cervical cancer by regulating miR-508-3p/RGS17 axis.
    Life Sci. 2019 Aug 24:116789. doi: 10.1016/j.lfs.2019.116789.
    Abstract    

    Abstract available

  11. YANG XM, Wu ZM, Huang H, Chu XY, et al
    Estrogen receptor 1 mutations in 260 cervical cancer samples from Chinese patients.
    Oncol Lett. 2019;18:2771-2776.
    Abstract    

    Abstract available

  12. YU J, Zheng Q, Ding X, Zheng B, et al
    Systematic re-analysis strategy of serum indices identifies alkaline phosphatase as a potential predictive factor for cervical cancer.
    Oncol Lett. 2019;18:2356-2365.
    Abstract    

    Abstract available

  13. ZHANG Y, Chen C, Zhang J
    Effects and significance of formononetin on expression levels of HIF-1alpha and VEGF in mouse cervical cancer tissue.
    Oncol Lett. 2019;18:2248-2253.
    Abstract    

    Abstract available

  14. YANG J, Tian G, Pan Z, Zhao F, et al
    Nomograms for predicting the survival rate for cervical cancer patients who undergo radiation therapy: a SEER analysis.
    Future Oncol. 2019 Aug 27. doi: 10.2217/fon-2019-0029.
    Abstract    

    Abstract available

  15. TAVAKOLIAN S, Goudarzi H, Eslami G, Faghihloo E, et al
    Transcriptional Regulation of Epithelial to Mesenchymal Transition Related Genes by Lipopolysaccharide in Human Cervical Cancer Cell Line HeLa.
    Asian Pac J Cancer Prev. 2019;20:2455-2461.
    Abstract    

    Abstract available

  16. SPAGNOLETTI BRM, Bennett LR, Wahdi AE, Wilopo SA, et al
    A Qualitative Study of Parental Knowledge and Perceptions of Human Papillomavirus and Cervical Cancer Prevention in Rural Central Java, Indonesia: Understanding Community Readiness for Prevention Interventions.
    Asian Pac J Cancer Prev. 2019;20:2429-2434.
    Abstract    

    Abstract available

  17. SABEENA S, Kuriakose S, Binesh D, Abdulmajeed J, et al
    The Utility of Urine-Based Sampling for Cervical Cancer Screening in Low-Resource Settings.
    Asian Pac J Cancer Prev. 2019;20:2409-2413.
    Abstract    

    Abstract available

  18. WONG CL, Choi KC, Law BMH, Chan DNS, et al
    Effects of a Community Health Worker-Led Multimedia Intervention on the Uptake of Cervical Cancer Screening among South Asian Women: A Pilot Randomized Controlled Trial.
    Int J Environ Res Public Health. 2019;16.
    Abstract    

    Abstract available

  19. DA COSTA SCS, Bonadio RC, Gabrielli FCG, Aranha AS, et al
    Neoadjuvant Chemotherapy With Cisplatin and Gemcitabine Followed by Chemoradiation Versus Chemoradiation for Locally Advanced Cervical Cancer: A Randomized Phase II Trial.
    J Clin Oncol. 2019 Aug 26:JCO1900674. doi: 10.1200/JCO.19.00674.
    Abstract    

    Abstract available

  20. IIDA T, Muramatsu T, Nakajima R, Narayama C, et al
    Recurrent Cervical Cancer with Intestinal Perforation That Was Related to Bevacizumab after Long-term NSAIDs Administration and Was Treated with Laparoscopy-assisted Anastomosis.
    Tokai J Exp Clin Med. 2019;44:40-44.
    Abstract    

    Abstract available

  21. DONG X, Du H, Guan H, Zhang X, et al
    Multiscale Time-Sharing Elastography Algorithms and Transfer Learning of Clinicopathological Features of Uterine Cervical Cancer for Medical Intelligent Computing System.
    J Med Syst. 2019;43:310.
    Abstract    

    Abstract available

  22. ZHAO X, Zhu W, Zhang R, Zhang M, et al
    Targeted juglone blocks the invasion and metastasis of HPV-positive cervical cancer cells.
    J Pharmacol Sci. 2019 Aug 10. pii: S1347-8613(19)35696.
    Abstract    

    Abstract available

  23. CANLORBE G, Leveque J, Koskas M
    [Should the results of the LACC trial modify French practices for the choice of surgical approach for the treatment of early-stage cervical cancer ? The point of view of the CNGOF Cancer Commission].
    Bull Cancer. 2019 Aug 21. pii: S0007-4551(19)30253.
    Abstract    



  24. AREDES MA, da Camara AO, de Paula NS, Fraga KYD, et al
    Efficacy of omega-3 supplementation on nutritional status, skeletal muscle, and chemoradiotherapy toxicity in cervical cancer patients: A randomized, triple-blind, clinical trial conducted in a middle-income country.
    Nutrition. 2019;67-68:110528.
    Abstract    

    Abstract available

  25. RONG X, Gao W, Yang X, Guo J, et al
    Downregulation of hsa_circ_0007534 restricts the proliferation and invasion of cervical cancer through regulating miR-498/BMI-1 signaling.
    Life Sci. 2019 Aug 21:116785. doi: 10.1016/j.lfs.2019.116785.
    Abstract    

    Abstract available

  26. NOVACKOVA M, Pastor Z, Chmel R Jr, Brtnicky T, et al
    Urinary tract morbidity after nerve-sparing radical hysterectomy in women with cervical cancer.
    Int Urogynecol J. 2019 Aug 23. pii: 10.1007/s00192-019-04083.
    Abstract    

    Abstract available

  27. DROLET M, Benard E, Perez N, Brisson M, et al
    Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis.
    Lancet. 2019 Jun 26. pii: S0140-6736(19)30298.
    Abstract    

    Abstract available

  28. CHAO YS, McCormack S, Datta S, Pink J, et al
    Assessing the cost-effectiveness of HPV vaccination strategies for adolescent girls and boys in the UK.
    BMC Infect Dis. 2019;19:552.
    Abstract    

    Abstract available

  29. OKUHARA T, Ishikawa H, Okada M, Kato M, et al
    Newspaper coverage before and after the HPV vaccination crisis began in Japan: a text mining analysis.
    BMC Public Health. 2019;19:770.
    Abstract    

    Abstract available

  30. VAN DAM PA, Verhoeven Y, Jacobs J, Wouters A, et al
    RANK-RANKL Signaling in Cancer of the Uterine Cervix: A Review.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  31. VERMA N
    When Darkness Starts.
    Perspect Biol Med. 2019;62:153-158.
    Abstract    

    Abstract available

  32. SHI X, Wang J, Lei Y, Cong C, et al
    Research progress on the PI3K/AKT signaling pathway in gynecological cancer (Review).
    Mol Med Rep. 2019;19:4529-4535.
    Abstract    

    Abstract available

  33. KIM G, Taye J, Yu K, Park S, et al
    HPV E6/E7, hTERT, and Ki67 mRNA RT-qPCR Assay for Detecting High-Grade Cervical Lesion with Microscope Slides.
    Anal Cell Pathol (Amst). 2019;2019:9365654.
    Abstract    

    Abstract available

  34. GAO S, Du S, Lu Z, Xin J, et al
    Multiparametric PET/MR (PET and MR-IVIM) for the evaluation of early treatment response and prediction of tumor recurrence in patients with locally advanced cervical cancer.
    Eur Radiol. 2019 Sep 6. pii: 10.1007/s00330-019-06428.
    Abstract    

    Abstract available

  35. AZUOGU BN, Umeokonkwo CD, Azuogu VC, Onwe OE, et al
    Appraisal of willingness to vaccinate daughters with human papilloma virus vaccine and cervical cancer screening uptake among mothers of adolescent students in Abakaliki, Nigeria.
    Niger J Clin Pract. 2019;22:1286-1291.
    Abstract    

    Abstract available

  36. KIM MY, Kim YS, Kim M, Choi MY, et al
    Metformin inhibits cervical cancer cell proliferation via decreased AMPK O-GlcNAcylation.
    Anim Cells Syst (Seoul). 2019;23:302-309.
    Abstract    

    Abstract available

  37. DONATUS L, Nina FK, Sama DJ, Nkfusai CN, et al
    Assessing the uptake of cervical cancer screening among women aged 25-65 years in Kumbo West Health District, Cameroon.
    Pan Afr Med J. 2019;33:106.
    Abstract    

    Abstract available

  38. PRANATHARTHI A, Thomas P, Udayashankar AH, Bhavani C, et al
    RhoC regulates radioresistance via crosstalk of ROCK2 with the DNA repair machinery in cervical cancer.
    J Exp Clin Cancer Res. 2019;38:392.
    Abstract    

    Abstract available

  39. OLUSOLA P, Ousley K, Ndetan H, Singh KP, et al
    Cervical Cancer Prevention in Racially Disparate Rural Populations.
    Medicines (Basel). 2019;6.
    Abstract    

    Abstract available

  40. WANG AH, Zhao JM, Du J, Pang QX, et al
    Long noncoding RNA LUCAT1 promotes cervical cancer cell proliferation and invasion by upregulating MTA1.
    Eur Rev Med Pharmacol Sci. 2019;23:6824-6829.
    Abstract    

    Abstract available

  41. KUBITSCHKE H, Wolf B, Morawetz E, Horn LC, et al
    Roadmap to Local Tumour Growth: Insights from Cervical Cancer.
    Sci Rep. 2019;9:12768.
    Abstract    

    Abstract available

  42. ZHEN HN, Tian Y, Shen J, Ma JB, et al
    [Sexual Quality of Life in Patients with Cervical Cancer Undergoing Radiotherapy].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:501-505.
    Abstract    

    Abstract available

  43. YANG J, Liang B, Hou S
    TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
    J Gene Med. 2019 Sep 4:e3125. doi: 10.1002/jgm.3125.
    Abstract    

    Abstract available

  44. ALJAKOUCH K, Hilal Z, Daho I, Schuler M, et al
    Fast Non-invasive Diagnosis of Cervical Cancer by Coherent anti-Stokes Raman Scattering.
    Anal Chem. 2019 Sep 4. doi: 10.1021/acs.analchem.9b03395.
    Abstract    

    Abstract available

  45. TATAR O, Wade K, McBride E, Thompson E, et al
    Are Health Care Professionals Prepared to Implement Human Papillomavirus Testing? A Review of Psychosocial Determinants of Human Papillomavirus Test Acceptability in Primary Cervical Cancer Screening.
    J Womens Health (Larchmt). 2019 Sep 3. doi: 10.1089/jwh.2019.7678.
    Abstract    

    Abstract available

  46. GEORGE R, Prasoona TS, Kandasamy R, Mani T, et al
    Regular Low-Dose Oral Metronidazole Is Associated With Fewer Vesicovaginal and Rectovaginal Fistulae in Recurrent Cervical Cancer: Results From a 10-Year Retrospective Cohort.
    J Glob Oncol. 2019;5:1-10.
    Abstract    

    Abstract available

  47. ASALI F, Abdel-Razeq R, Al-Thunaibat A, Okour A, et al
    Jordanian women's attitudes towards cervical cancer screening: has the pattern changed?
    J Obstet Gynaecol. 2019 Sep 3:1-5. doi: 10.1080/01443615.2019.1635097.
    Abstract    

    Abstract available

  48. HAN L, Husaiyin S, Ma C, Niyazi M, et al
    Association study between the polymorphisms of angiogenesis-related genes and cervical cancer susceptibility in Chinese Uygur population.
    Mol Genet Genomic Med. 2019 Sep 2:e899. doi: 10.1002.
    Abstract    

    Abstract available

  49. KIM J, Kim BK, Jeon DS, Lee CH, et al
    Type-Specific Viral Load and Physical State of HPV Type 16, 18, and 58 as Diagnostic Biomarkers for High-Grade Squamous Intraepithelial Lesions or Cervical Cancer.
    Cancer Res Treat. 2019 Aug 28. pii: crt.2019.152. doi: 10.4143/crt.2019.
    Abstract    

    Abstract available

  50. LIN Y, Ouyang Y, Chen K, Lu Z, et al
    Clinical Outcomes of Volumetric Modulated Arc Therapy Following Intracavitary/Interstitial Brachytherapy in Cervical Cancer: A Single Institution Retrospective Experience.
    Front Oncol. 2019;9:760.
    Abstract    

    Abstract available

  51. MBURU A, Itsura P, Mabeya H, Kaaria A, et al
    Knowledge of Cervical Cancer and Acceptability of Prevention Strategies Among Human Papillomavirus-Vaccinated and Human Papillomavirus-Unvaccinated Adolescent Women in Eldoret, Kenya.
    Biores Open Access. 2019;8:139-145.
    Abstract    

    Abstract available

  52. SUN Q, Yang Z, Li P, Wang X, et al
    A novel miRNA identified in GRSF1 complex drives the metastasis via the PIK3R3/AKT/NF-kappaB and TIMP3/MMP9 pathways in cervical cancer cells.
    Cell Death Dis. 2019;10:636.
    Abstract    

    Abstract available

  53. NESSLER K, Chan SKF, Ball F, Storman M, et al
    Impact of family physicians on cervical cancer screening: cross-sectional questionnaire-based survey in a region of southern Poland.
    BMJ Open. 2019;9:e031317.
    Abstract    

    Abstract available

  54. TCHOUNGA B, Boni SP, Koffi JJ, Horo AG, et al
    Cervical cancer screening uptake and correlates among HIV-infected women: a cross-sectional survey in Cote d'Ivoire, West Africa.
    BMJ Open. 2019;9:e029882.
    Abstract    

    Abstract available

  55. ZHAO M, Gu L, Li Y, Chen S, et al
    Chitooligosaccharides display anti-tumor effects against human cervical cancer cells via the apoptotic and autophagic pathways.
    Carbohydr Polym. 2019;224:115171.
    Abstract    

    Abstract available

  56. AASBO G, Solbraekke KN, Waller J, Trope A, et al
    Perspectives of non-attenders for cervical cancer screening in Norway: a qualitative focus group study.
    BMJ Open. 2019;9:e029505.
    Abstract    

    Abstract available

  57. MUKAI Y, Koike I, Matsunaga T, Yokota NR, et al
    Radiation Therapy for Uterine Cervical Cancer With Lung Metastases Including Oligometastases.
    In Vivo. 2019;33:1677-1684.
    Abstract    

    Abstract available

  58. KOBAYASHI K, Murakami N, Takahashi K, Inaba K, et al
    Local Radiotherapy or Chemotherapy for Oligo-recurrent Cervical Cancer in Patients With Prior Pelvic Irradiation.
    In Vivo. 2019;33:1659-1665.
    Abstract    

    Abstract available

  59. SURADEJ B, Sookkhee S, Panyakaew J, Mungkornasawakul P, et al
    Kaempferia parviflora Extract Inhibits STAT3 Activation and Interleukin-6 Production in HeLa Cervical Cancer Cells.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  60. CHEN LM, Liu L, Tao X, He Y, et al
    [Analysis of recurrence and its influencing factors in patients with cervical HSIL within 24 months after LEEP].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:534-540.
    Abstract    

    Abstract available

  61. CHAO YS, McCormack S, Sehnal B, Slama J, et al
    The changes in FIGO staging for carcinoma of the cervix uteri.
    Ceska Gynekol. 2019;84:216-221.
    Abstract    

    Abstract available

  62. HONG CM, Park SH, Chong GO, Lee YH, et al
    Enhancing prognosis prediction using pre-treatment nodal SUVmax and HPV status in cervical squamous cell carcinoma.
    Cancer Imaging. 2019;19:43.
    Abstract    

    Abstract available

  63. STARODUBTSEVA NL, Brzhozovskiy AG, Bugrova AE, Kononikhin AS, et al
    Label-free cervicovaginal fluid proteome profiling reflects the cervix neoplastic transformation.
    J Mass Spectrom. 2019;54:693-703.
    Abstract    

    Abstract available

  64. YAN C, Liang N, Li Q, Yan P, et al
    Biotin and arginine modified hydroxypropyl-beta-cyclodextrin nanoparticles as novel drug delivery systems for paclitaxel.
    Carbohydr Polym. 2019;216:129-139.
    Abstract    

    Abstract available

  65. ACUCENA VIEIRA ALVES S, Schiaveto de Souza A, Weller M, Pires Batiston A, et al
    Differential Impact of Education Level, Occupation and Marital Status on Performance of the Papanicolaou Test among Women from Various Regions in Brazil
    Asian Pac J Cancer Prev. 2019;20:1037-1044.
    Abstract    

    Abstract available

  66. WUDTISAN J, Tantipalakorn C, Charoenkwan K, Sreshthaputra RA, et al
    Factors Associated with Development of High-Grade Squamous Intraepithelial Lesions of the Uterine Cervix in Women Younger than 30 Years
    Asian Pac J Cancer Prev. 2019;20:1031-1036.
    Abstract    

    Abstract available

  67. LI N, Zhang FB, Li BJ, Wang RT, et al
    Combination of Preoperative D-Dimer and Platelet Distribution width Predicts Postoperative Deep Venous Thrombosis in Patients with Cervical Carcinoma
    Asian Pac J Cancer Prev. 2019;20:1025-1029.
    Abstract    

    Abstract available

  68. DOS SANTOS AV, dos Santos GT, Brackmann RL, Prolla JC, et al
    Follow-Up of Women with Cervical Cytological Abnormalities: Progression and Regression Events
    Asian Pac J Cancer Prev. 2019;20:1019-1024.
    Abstract    

    Abstract available

  69. FARES E, McCloskey CB, Gutierrez A, Princiotta M, et al
    Vaccine strain Listeria monocytogenes bacteremia occurring 31 months after immunization.
    Infection. 2019;47:489-492.
    Abstract    

    Abstract available

  70. OSTRBENK A, Xu L, Arbyn M, Poljak M, et al
    Clinical and analytical evaluation of the Anyplex II HPV HR Detection assay within the VALGENT-3 framework.
    J Clin Microbiol. 2018 Sep 12. pii: JCM.01176-18. doi: 10.1128/JCM.01176.
    Abstract    

    Abstract available

  71. SINDHWANI A, Muthusammy S, Bhatia A
    Vitamin C may exert variable effects on viability and proliferation of HeLa cells exhibiting high and low chromosomal instability.
    Adv Clin Exp Med. 2019;28:19-24.
    Abstract    

    Abstract available

  72. DUAN H, Li X, Chen Y, Wang Y, et al
    LncRNA RHPN1-AS1 promoted cell proliferation, invasion and migration in cervical cancer via the modulation of miR-299-3p/FGF2 axis.
    Life Sci. 2019 Sep 13:116856. doi: 10.1016/j.lfs.2019.116856.
    Abstract    

    Abstract available


  73. Cervical Cancer, Febrile Seizures, HIV Infection, Dyspepsia.
    Am Fam Physician. 2019;100:331.
    Abstract    



  74. LU Y, Peng W, Song J, Chen T, et al
    On the potential use of dynamic contrast-enhanced (DCE) MRI parameters as radiomics features of cervical cancer.
    Med Phys. 2019 Sep 16. doi: 10.1002/mp.13821.
    Abstract    

    Abstract available

  75. TANG B, Liu X, Wang X, Kang S, et al
    Dosimetric comparison of graphical optimization and inverse planning simulated annealing for brachytherapy of cervical cancer.
    J Contemp Brachytherapy. 2019;11:379-383.
    Abstract    

    Abstract available

  76. PALLED SR, Tanvirpasha CAR, Naveen T, Sathiyan S, et al
    Magnetic resonance image-based 3D volume interstitial brachytherapy using polyether ether ketone catheters in advanced cervical cancer - a feasibility study.
    J Contemp Brachytherapy. 2019;11:307-311.
    Abstract    

    Abstract available

  77. MAHANTSHETTY U, Gudi S, Singh R, Sasidharan A, et al
    Indian Brachytherapy Society Guidelines for radiotherapeutic management of cervical cancer with special emphasis on high-dose-rate brachytherapy.
    J Contemp Brachytherapy. 2019;11:293-306.
    Abstract    

    Abstract available

  78. WANG JM, Wang Y, Huang YQ, Wang H, et al
    Prognostic Values of Platelet-Associated Indicators in Resectable Cervical Cancer.
    Dose Response. 2019;17:1559325819874199.
    Abstract    

    Abstract available

  79. HERBERT A, Culora G, McLean E, Kubba AA, et al
    Invasive cervical cancer after treatment of CIN.
    J Am Soc Cytopathol. 2019 Aug 16. pii: S2213-2945(19)30104.
    Abstract    

    Abstract available

  80. WALTER FM, Moodley JR
    Population risk factors for late-stage presentation of cervical cancer in sub-Saharan Africa.
    Cancer Epidemiol. 2019 Sep 12:101597. doi: 10.1016/j.canep.2019.101597.
    Abstract    



  81. DONG Z, Yu C, Rezhiya K, Gulijiahan A, et al
    Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway.
    Artif Cells Nanomed Biotechnol. 2019;47:3711-3719.
    Abstract    

    Abstract available

  82. VERGOTE I, Magrina JF, Zanagnolo V, Magtibay PM, et al
    The LACC Trial and Minimally Invasive Surgery in Cervical Cancer.
    J Minim Invasive Gynecol. 2019 Sep 11. pii: S1553-4650(19)31178.
    Abstract    



  83. TAMARI K, Sano K, Li Z, Seo Y, et al
    Ro 90-7501 Is a Novel Radiosensitizer for Cervical Cancer Cells that Inhibits ATM Phosphorylation.
    Anticancer Res. 2019;39:4805-4810.
    Abstract    

    Abstract available

  84. NOWAKOWSKI A, Arbyn M, Turkot MH, Wieszczy P, et al
    A roadmap for a comprehensive control of cervical cancer in Poland: integration of available solutions into current practice in primary and secondary prevention.
    Eur J Cancer Prev. 2019 Sep 11. doi: 10.1097/CEJ.0000000000000528.
    Abstract    

    Abstract available

  85. COLPAERT C, Jacomen G, Van de Vijver K, Baldewijns M, et al
    Ultrastaging of sentinel lymph nodes in gynecological cancer: Repeating the story of breast cancer? Letter to the editor, Reply to Cibula D, McCluggage WG. Sentinel lymph node (SLN) concept in cervical cancer: Current limitations and unanswered questi
    Gynecol Oncol Rep. 2019;29:130-131.
    Abstract    



  86. MISHRA GA, Pimple SA, Gupta SD
    Cervical Cancer Screening in Low Resource Settings: Cytology versus HPV Triage for VIA Positive Women.
    Int J Prev Med. 2019;10:138.
    Abstract    

    Abstract available

  87. MENDOZA-ALMANZA G, Ortiz-Sanchez E, Rocha-Zavaleta L, Rivas-Santiago C, et al
    Cervical cancer stem cells and other leading factors associated with cervical cancer development.
    Oncol Lett. 2019;18:3423-3432.
    Abstract    

    Abstract available

  88. GUO W, Yu H, Zhang L, Chen X, et al
    Effect of hyperoside on cervical cancer cells and transcriptome analysis of differentially expressed genes.
    Cancer Cell Int. 2019;19:235.
    Abstract    

    Abstract available

  89. PATEL H, Sherman SM, Tincello D, Moss EL, et al
    Awareness of and attitudes towards cervical cancer prevention among migrant Eastern European women in England.
    J Med Screen. 2019 Sep 12:969141319869957. doi: 10.1177/0969141319869957.
    Abstract    



  90. WANG Q, Zhang L, Yan Z, Xie L, et al
    OScc: an online survival analysis web server to evaluate the prognostic value of biomarkers in cervical cancer.
    Future Oncol. 2019 Sep 12. doi: 10.2217/fon-2019-0412.
    Abstract    

    Abstract available

  91. JOO J, Omae Y, Hitomi Y, Park B, et al
    The association of integration patterns of human papilloma virus and single nucleotide polymorphisms on immune- or DNA repair-related genes in cervical cancer patients.
    Sci Rep. 2019;9:13132.
    Abstract    

    Abstract available

  92. WONG OGW, Ng IFY, Tsun OKL, Pang HH, et al
    Machine learning interpretation of extended human papillomavirus genotyping by Onclarity in an Asian cervical cancer screening population.
    J Clin Microbiol. 2019 Sep 11. pii: JCM.00997-19. doi: 10.1128/JCM.00997.
    Abstract    

    Abstract available

  93. COSTANTINO C, Mazzucco W, Marotta C, Saporito L, et al
    Methodological issues in a cross-sectional survey on cervical cancer screening using telephone interviews in Sicily (Italy): a SWOT analysis.
    J Int Med Res. 2019 Sep 11:300060519860950. doi: 10.1177/0300060519860950.
    Abstract    



  94. LOPES VAS, Ribeiro JM
    Cervical cancer control limiting factors and facilitators: a literature review.
    Cien Saude Colet. 2019;24:3431-3442.
    Abstract    

    Abstract available

  95. WANG Y, Han S, You X, Shi X, et al
    The role of low density lipoprotein receptor-related protein 11 as a tumor promoter in cervical cancer.
    Cancer Manag Res. 2019;11:8081-8093.
    Abstract    

    Abstract available

  96. KOBAYASHI D, Okonogi N, Wakatsuki M, Miyasaka Y, et al
    Impact of CT-based brachytherapy in elderly patients with cervical cancer.
    Brachytherapy. 2019 Sep 7. pii: S1538-4721(19)30022.
    Abstract    

    Abstract available

  97. DING FN, Gao BH, Wu X, Gong CW, et al
    miR-122-5p modulates the radiosensitivity of cervical cancer cells by regulating cell division cycle 25CDC25A.
    FEBS Open Bio. 2019 Sep 10. doi: 10.1002/2211-5463.12730.
    Abstract    

    Abstract available

  98. HEMMAT N, Baghi HB
    Association of Human Papillomavirus Infection and Inflammation in Cervical Cancer.
    Pathog Dis. 2019 Sep 2. pii: 5558235. doi: 10.1093.
    Abstract    

    Abstract available

  99. KANNO K, Andou M, Yanai S, Toeda M, et al
    Long-term oncological outcomes of minimally invasive radical hysterectomy for early-stage cervical cancer: A retrospective, single-institutional study in the wake of the LACC trial.
    J Obstet Gynaecol Res. 2019 Sep 9. doi: 10.1111/jog.14116.
    Abstract    

    Abstract available

  100. BENDIFALLAH S, de Foucher T, Bricou A, Ouldamer L, et al
    Cervical cancer recurrence: Proposal for a classification based on anatomical dissemination pathways and prognosis.
    Surg Oncol. 2019;30:40-46.
    Abstract    

    Abstract available

  101. OKUNADE KS
    Human papillomavirus and cervical cancer.
    J Obstet Gynaecol. 2019 Sep 10:1-7. doi: 10.1080/01443615.2019.1634030.
    Abstract    

    Abstract available

  102. PAULAUSKIENE J, Ivanauskiene R, Skrodeniene E, Petkeviciene J, et al
    Organised Versus Opportunistic Cervical Cancer Screening in Urban and Rural Regions of Lithuania.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  103. BOGANI G, Maggiore ULR, Rossetti D, Ditto A, et al
    Advances in laparoscopic surgery for cervical cancer.
    Crit Rev Oncol Hematol. 2019;143:76-80.
    Abstract    

    Abstract available

  104. FENG S, Liu W, Bai X, Pan W, et al
    LncRNA-CTS promotes metastasis and epithelial-to-mesenchymal transition through regulating miR-505/ZEB2 axis in cervical cancer.
    Cancer Lett. 2019;465:105-117.
    Abstract    

    Abstract available

  105. PULATI N, Zhang Z, Gulimilamu A, Qi X, et al
    HPV16(+) -miRNAs in cervical cancer and miR-5701 plays an anti-tumor role in cervical cancer.
    J Gene Med. 2019 Sep 9:e3126. doi: 10.1002/jgm.3126.
    Abstract    

    Abstract available

  106. WANG X, Zhang J, Wang Y
    Long noncoding RNA GAS5-AS1 suppresses growth and metastasis of cervical cancer by increasing GAS5 stability.
    Am J Transl Res. 2019;11:4909-4921.
    Abstract    

    Abstract available

  107. YIN Z, Tang H, Li L, Ni J, et al
    Impact of sites versus number of metastases on survival of patients with organ metastasis from newly diagnosed cervical cancer.
    Cancer Manag Res. 2019;11:7759-7766.
    Abstract    

    Abstract available

  108. XIA C, Hu S, Xu X, Zhao X, et al
    Projections up to 2100 and a budget optimisation strategy towards cervical cancer elimination in China: a modelling study.
    Lancet Public Health. 2019;4:e462-e472.
    Abstract    

    Abstract available

  109. MALAGON T
    Reasons for optimism about eliminating cervical cancer in China.
    Lancet Public Health. 2019;4:e434-e435.
    Abstract    



  110. HAILE EL, Cindy S, Ina B, Belay G, et al
    HPV testing on vaginal/cervical nurse-assisted self-samples versus clinician-taken specimens and the HPV prevalence, in Adama Town, Ethiopia.
    Medicine (Baltimore). 2019;98:e16970.
    Abstract    

    Abstract available

  111. KUMAR T, Achkar S, Haie-Meder C, Chargari C, et al
    [Multimodal imaging guided brachytherapy: the example of cervical cancer].
    Cancer Radiother. 2019 Aug 23. pii: S1278-3218(19)30321.
    Abstract    

    Abstract available

  112. BI ZF, Li YF, Wei FX, Su YY, et al
    [Introduction of papillomavirus rapid interface for modelling and economics (PRIME) and an example of China's data analysis].
    Zhonghua Yu Fang Yi Xue Za Zhi. 2019;53:744-751.
    Abstract    

    Abstract available

  113. XIAO S, Xie H, Zhu X, Li X, et al
    Study on the Significance of Folate Receptor-Mediated Staining Solution (FRD) Staining in Screening High Grade Cervical Lesions.
    Med Sci Monit. 2019;25:2792-2801.
    Abstract    

    Abstract available

  114. DUMONT F, Duchalais E, Joseph S, Thibaudeau E, et al
    Laparoscopic total pelvic exenteration via an extraperitoneal approach.
    Surg Oncol. 2019;28:109.
    Abstract    



  115. GOTTWALD L, Moszynska-Zielinska M, Zytko L, Tomalczyk A, et al
    Prolonged retention of the Lippes loop intrauterine device as a cause of vaginal bleeding 10 years after chemoradiotherapy of locally advanced cervical carcinoma: case report and review of the literature.
    J Obstet Gynaecol. 2019;39:131-132.
    Abstract    



  116. SRIPAN P, Chitapanarux I, Fidler-Benaoudia MM, Miranda-Filho A, et al
    Impact of universal health care and screening on incidence and survival of Thai women with cervical cancer: A population-based study of the Chiang Mai Province.
    Cancer Epidemiol. 2019;63:101594.
    Abstract    

    Abstract available

  117. MAVER PJ, Poljak M
    Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans.
    Clin Microbiol Infect. 2019 Sep 17. pii: S1198-743X(19)30491.
    Abstract    

    Abstract available

  118. WEI YQ, Jiao XL, Zhang SY, Xu Y, et al
    MiR-9-5p could promote angiogenesis and radiosensitivity in cervical cancer by targeting SOCS5.
    Eur Rev Med Pharmacol Sci. 2019;23:7314-7326.
    Abstract    

    Abstract available

  119. TIAN Y, Wang YR, Jia SH
    Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.
    Eur Rev Med Pharmacol Sci. 2019;23:7307-7313.
    Abstract    

    Abstract available

  120. ZHAO H, Hu GM, Wang WL, Wang ZH, et al
    LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.
    Eur Rev Med Pharmacol Sci. 2019;23:7295-7306.
    Abstract    

    Abstract available

  121. LIU H, Lee G, Lee JI, Ahn TG, et al
    Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines.
    Obstet Gynecol Sci. 2019;62:322-328.
    Abstract    

    Abstract available

  122. XU H, Yu Y, George W, Smith JS, et al
    Comparison of the performance of paired urine and cervical samples for cervical cancer screening in screening population.
    J Med Virol. 2019 Sep 19. doi: 10.1002/jmv.25597.
    Abstract    

    Abstract available

  123. ZHAO J, Guo Z, Wang Q, Si T, et al
    HPV infection associated DNA damage correlated with cervical precancerous lesions and cancer in the highest area of cervical cancer mortality, Longnan, China.
    Cancer Manag Res. 2019;11:7197-7210.
    Abstract    

    Abstract available


  124. Effects of green synthesised silver nanoparticles (ST06-AgNPs) using curcumin derivative (ST06) on human cervical cancer cells (HeLa) in vitro and EAC tumor bearing mice models [Corrigendum].
    Int J Nanomedicine. 2019;14:6133.
    Abstract    



  125. JORGENSEN L, Gotzsche PC, Jefferson T
    Increased incidence of cervical cancer in Sweden: an unlikely link with human papillomavirus (HPV) vaccination.
    BMJ Sex Reprod Health. 2019 Sep 18. pii: bmjsrh-2018-200245.
    Abstract    



  126. KAGABU M, Nagasawa T, Fukagawa D, Tomabechi H, et al
    Immunotherapy for Uterine Cervical Cancer.
    Healthcare (Basel). 2019;7.
    Abstract    

    Abstract available

  127. LEETANAPORN K, Hanprasertpong J
    Impact of Obesity on Clinical Outcomes in Patients with Early-Stage Cervical Cancer after Radical Hysterectomy with Pelvic Node Dissection.
    Oncol Res Treat. 2019 Sep 18:1-8. doi: 10.1159/000502752.
    Abstract    

    Abstract available

  128. LIU C, Wang X, Zhang Y
    The Roles of HK2 on Tumorigenesis of Cervical Cancer.
    Technol Cancer Res Treat. 2019;18:1533033819871306.
    Abstract    

    Abstract available

  129. KIM BH, Chang JH
    Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer.
    Sci Rep. 2019;9:13301.
    Abstract    

    Abstract available

  130. KHUMKHRONG P, Piboonprai K, Chaichompoo W, Pimtong W, et al
    Crinamine Induces Apoptosis and Inhibits Proliferation, Migration, and Angiogenesis in Cervical Cancer SiHa Cells.
    Biomolecules. 2019;9.
    Abstract    

    Abstract available

  131. ZHU L, Yu CL, Zheng Y
    NSD2 inhibition suppresses metastasis in cervical cancer by promoting TGF-beta/TGF-betaRI/SMADs signaling.
    Biochem Biophys Res Commun. 2019 Sep 14. pii: S0006-291X(19)31522.
    Abstract    

    Abstract available

  132. DELIA P, Sansotta G, Pontoriero A, Iati G, et al
    Clinical Evaluation of Low-Molecular-Weight Hyaluronic Acid-Based Treatment on Onset of Acute Side Effects in Women Receiving Adjuvant Radiotherapy after Cervical Surgery: A Randomized Clinical Trial.
    Oncol Res Treat. 2019;42:217-223.
    Abstract    

    Abstract available

  133. LI P, Zhang Q, Tang H
    INPP1 up-regulation by miR-27a contributes to the growth, migration and invasion of human cervical cancer.
    J Cell Mol Med. 2019 Sep 26. doi: 10.1111/jcmm.14644.
    Abstract    

    Abstract available

  134. OKAN Y, Petrova D, Smith SG, Lesic V, et al
    How Do Women Interpret the NHS Information Leaflet about Cervical Cancer Screening?
    Med Decis Making. 2019 Sep 26:272989X19873647. doi: 10.1177/0272989X19873647.
    Abstract    

    Abstract available

  135. MATAMOROS JA, da Silva MIF, de Moura PMMF, Leitao MDCG, et al
    Reduced Expression of IL-1beta and IL-18 Proinflammatory Interleukins Increases the Risk of Developing Cervical Cancer.
    Asian Pac J Cancer Prev. 2019;20:2715-2721.
    Abstract    

    Abstract available

  136. ORTASHI O, Abdalla D
    Colposcopic and Histological Outcome of Atypical Squamous Cells of Undetermined Significance and Atypical Squamous Cell of Undetermined Significance Cannot Exclude High-Grade in Women Screened for Cervical Cancer.
    Asian Pac J Cancer Prev. 2019;20:2579-2582.
    Abstract    

    Abstract available

  137. ZHANG J, Sha Z, Gu Y, Li Y, et al
    Predicting Behavioral Intentions Related to Cervical Cancer Screening Using a Three-Level Model for the TPB and SCT in Nanjing, China.
    Int J Environ Res Public Health. 2019;16.
    Abstract    

    Abstract available

  138. YOSHIDA K, Kajiyama H, Yoshihara M, Tamauchi S, et al
    The role of additional hysterectomy after concurrent chemoradiation for patients with locally advanced cervical cancer.
    Int J Clin Oncol. 2019 Sep 24. pii: 10.1007/s10147-019-01551.
    Abstract    

    Abstract available

  139. JAYAMOHAN S, Kannan M, Moorthy RK, Rajasekaran N, et al
    Dysregulation of miR-375/AEG-1 Axis by Human Papillomavirus 16/18-E6/E7 Promotes Cellular Proliferation, Migration, and Invasion in Cervical Cancer.
    Front Oncol. 2019;9:847.
    Abstract    

    Abstract available

  140. NGOMA M, Autier P
    Cancer prevention: cervical cancer.
    Ecancermedicalscience. 2019;13:952.
    Abstract    

    Abstract available

  141. WANG YT, Li B, Li XG, Ma SK, et al
    [Efficacy and side effect analysis of paclitaxel liposome for neoadjuvant chemotherapy in locally advanced cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:588-594.
    Abstract    

    Abstract available

  142. LEE J, Kim CK, Park SY
    Histogram analysis of apparent diffusion coefficients for predicting pelvic lymph node metastasis in patients with uterine cervical cancer.
    MAGMA. 2019 Sep 23. pii: 10.1007/s10334-019-00777.
    Abstract    

    Abstract available

  143. SUN JJ, Li HL, Ma H, Shi Y, et al
    SMYD2 promotes cervical cancer growth by stimulating cell proliferation.
    Cell Biosci. 2019;9:75.
    Abstract    

    Abstract available

  144. MATSUURA Y, Yoshioka M, Nakata A, Haraga M, et al
    Trends in Uterine Cervical Cancer Screening at Physical Health Checkups for Company Employees in Japan.
    J UOEH. 2019;41:327-333.
    Abstract    

    Abstract available

  145. NISHIZUKA M, Komada R, Imagawa M
    Knockdown of RhoE Expression Enhances TGF-beta-Induced EMT (epithelial-to-mesenchymal transition) in Cervical Cancer HeLa Cells.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  146. PATEL H, Sherman SM, Pcolkina K, Strazdina K, et al
    Barriers and motivators for uptake of cervical cancer prevention strategies in Eastern Europe: the perspective from Latvia.
    Acta Dermatovenerol Alp Pannonica Adriat. 2019;28:107-111.
    Abstract    

    Abstract available

  147. MA H, Tian T, Liu X, Xia M, et al
    Upregulated circ_0005576 facilitates cervical cancer progression via the miR-153/KIF20A axis.
    Biomed Pharmacother. 2019;118:109311.
    Abstract    

    Abstract available

  148. COX B, Fitzgerald P, Austin RM, Sneyd MJ, et al
    The impact of primary HPV screening on the incidence of cervical cancer in New Zealand.
    J Am Soc Cytopathol. 2019;8:258-264.
    Abstract    

    Abstract available

  149. CUSIMANO MC, Ferguson SE
    Pragmatic studies of minimally invasive radical hysterectomy for early-stage cervical cancer should be valued.
    Am J Obstet Gynecol. 2019 Sep 19. pii: S0002-9378(19)31124.
    Abstract    



  150. LIU L, Wang D, Dong H, Jin C, et al
    Characteristics of carcinogenic HPV genotypes in North China Plain and the association with cervical lesions.
    Medicine (Baltimore). 2019;98:e17087.
    Abstract    

    Abstract available

  151. DEL MISTRO A, Giorgi Rossi P, Frayle H, Pasquale L, et al
    Five-year risk of CIN3 after short-term HPV-DNA negativity in cytology-negative women: a population-based cohort study.
    BJOG. 2019;126:1365-1371.
    Abstract    

    Abstract available

  152. BERNICHON E, Espenel S, Mery B, Trone JC, et al
    [HPV: Carcinogenic implications and preventive measures].
    Presse Med. 2019;48.
    Abstract    

    Abstract available

  153. GUNEY G, Arslan E, Bas Y, Turgal E, et al
    Two-Year Results of Community-Based Screening Program for Human Papilloma Virus DNA in Corum Province.
    Turk Patoloji Derg. 2019;35:102-106.
    Abstract    

    Abstract available

  154. SILVERBERG MJ, Leyden WA, Lam JO, Gregorich SE, et al
    Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study.
    Lancet Child Adolesc Health. 2018;2:707-714.
    Abstract    

    Abstract available

  155. SAFAEIAN M, Castellsague X, Hildesheim A, Wacholder S, et al
    Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.
    J Infect Dis. 2018 Apr 30. pii: 4990620. doi: 10.1093.
    Abstract    

    Abstract available

  156. EISENBERG E, Shay L, Keidar Z, Amit A, et al
    Magnetic resonance guided focused ultrasound surgery for bone metastasis: from pain palliation to biological ablation?
    J Pain Symptom Manage. 2018 Apr 18. pii: S0885-3924(18)30216.
    Abstract    



  157. ALEXANDER C, White M, Maleki Z, Rodriguez EF, et al
    HPV-ISH-Negative Invasive Cervical Squamous Cell Carcinoma: Histologic and Pap Test Results.
    Acta Cytol. 2019;63:417-423.
    Abstract    

    Abstract available

  158. TOYODA S, Kawaguchi R, Kobayashi H
    Clinicopathological Characteristics of Atypical Glandular Cells Determined by Cervical Cytology in Japan: Survey of Gynecologic Oncology Data from the Obstetrical Gynecological Society of Kinki District, Japan.
    Acta Cytol. 2019;63:361-370.
    Abstract    

    Abstract available

  159. PORS J, Cheng A, Leo JM, Kinloch MA, et al
    A Comparison of GATA3, TTF1, CD10, and Calretinin in Identifying Mesonephric and Mesonephric-like Carcinomas of the Gynecologic Tract.
    Am J Surg Pathol. 2018 Aug 24. doi: 10.1097/PAS.0000000000001142.
    Abstract    

    Abstract available

  160. GILBERT DC, Wakeham K, Langley RE, Vale CL, et al
    Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Br J Cancer. 2018 Nov 28. pii: 10.1038/s41416-018-0273.
    Abstract    

    Abstract available

  161. PRINTZ C
    Cervical cancer subtype less detectable by Papanicolaou testing.
    Cancer. 2019;125:3287.
    Abstract    



  162. ORTIZ AP, Engels EA, Nogueras-Gonzalez GM, Colon-Lopez V, et al
    Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected hispanics living in the United States.
    Cancer. 2018 Oct 22. doi: 10.1002/cncr.31702.
    Abstract    

    Abstract available

  163. PRINTZ C
    Rethinking a common surgery technique for early cervical cancer: Experts are reconsidering the use of minimally invasive radical hysterectomy as a treatment for early cervical cancer after multiple studies found that patients who undergo the procedure
    Cancer. 2019;125:3485-3487.
    Abstract    



  164. FICHT AL, Lapidos-Salaiz I, Phelps BR
    Eliminating cervical cancer: Promising developments in primary prevention.
    Cancer. 2019 Sep 26. doi: 10.1002/cncr.32507.
    Abstract    



  165. PLACIDI A, Giorgi Rossi P
    The impact of blind peer review (team reading) of equivocal/abnormal Papanicolaou smears on inter-reader agreement.
    Cytopathology. 2019;30:105-108.
    Abstract    

    Abstract available

  166. KIMURA F, Kobayashi T, Kanai R, Kobayashi Y, et al
    Image quantification technology of the heterochromatin and euchromatin region for differential diagnosis in the lobular endocervical glandular hyperplasia.
    Diagn Cytopathol. 2019;47:553-563.
    Abstract    

    Abstract available

  167. STEVEN VS, Liselotte C, Jerina B, Ans T, et al
    Detection of human papillomavirus 67 single infection in high-grade cervical lesions: Case report and review of literature.
    Diagn Cytopathol. 2019;47:251-254.
    Abstract    



  168. DELOMENIE M, Bonsang-Kitzis H, Bats AS, Ngo C, et al
    The clinical implication of lymph nodes micrometastases and isolated tumor cells in patients with cervical cancer: A systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:71-76.
    Abstract    

    Abstract available

  169. TAN S, Tao Z, Bian X, Zhao Y, et al
    Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer.
    Eur J Obstet Gynecol Reprod Biol. 2019;241:99-103.
    Abstract    

    Abstract available

  170. GIL KM, Pugh SL, Klopp AH, Yeung AR, et al
    Expanded validation of the EPIC bowel and urinary domains for use in women with gynecologic cancer undergoing postoperative radiotherapy.
    Gynecol Oncol. 2019 May 16. pii: S0090-8258(19)31184.
    Abstract    

    Abstract available

  171. ANDERSEN B, Christensen BS, Christensen J, Ejersbo D, et al
    HPV-prevalence in elderly women in Denmark.
    Gynecol Oncol. 2019 May 11. pii: S0090-8258(19)31182.
    Abstract    

    Abstract available

  172. LUCIDO CT, Wynja E, Madeo M, Williamson CS, et al
    Innervation of cervical carcinoma is mediated by cancer-derived exosomes.
    Gynecol Oncol. 2019 Apr 16. pii: S0090-8258(19)31149.
    Abstract    

    Abstract available

  173. BJURBERG M, Holmberg E, Borgfeldt C, Floter-Radestad A, et al
    Primary treatment patterns and survival of cervical cancer in Sweden: A population-based Swedish Gynecologic Cancer Group Study.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31474.
    Abstract    

    Abstract available

  174. RADER JS, Pan A, Corbin B, Iden M, et al
    Identification and validation of a prognostic proteomic signature for cervical cancer.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31473.
    Abstract    

    Abstract available

  175. HIRAO N, Iwata T, Tanaka K, Nishio H, et al
    Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31478.
    Abstract    

    Abstract available

  176. SIMS TT, Colbert LE, Zheng J, Delgado Medrano AY, et al
    Gut microbial diversity and genus-level differences identified in cervical cancer patients versus healthy controls.
    Gynecol Oncol. 2019 Sep 6. pii: S0090-8258(19)31489.
    Abstract    

    Abstract available

  177. WOESTENBERG PJ, Bogaards JA, King AJ, Leussink S, et al
    Assessment of herd effects among women and heterosexual men after girls-only HPV16/18 vaccination in the Netherlands: A repeated cross-sectional study.
    Int J Cancer. 2019;144:2718-2727.
    Abstract    

    Abstract available

  178. BONI S, Tchounga B, Comoe K, Guie P, et al
    Assessment of the scale-up of cervical cancer screening in Abidjan stratified by HIV status.
    Int J Gynaecol Obstet. 2019 Sep 4. doi: 10.1002/ijgo.12959.
    Abstract    

    Abstract available

  179. MCKENZIE ND, Ahmad S, Bernard J Jr, DeGennaro V Jr, et al
    Empowering and training front-line providers treating cervical cancer in Haiti: perspective of a gynecologic oncologist's experience with international surgical missions.
    Int J Gynecol Cancer. 2019 Aug 26. pii: ijgc-2019-000758.
    Abstract    



  180. CHO WK, Kim YI, Park W, Yang K, et al
    Para-aortic lymph node recurrence after curative radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2019;29:1116-1120.
    Abstract    

    Abstract available

  181. FOKOM DOMGUE J, Manjuh F, Nulah K, Welty T, et al
    Onsite training of clinicians on new techniques to improve cervical cancer prevention in sub-Saharan Africa.
    Int J Gynecol Cancer. 2019 Aug 30. pii: ijgc-2019-000772.
    Abstract    



  182. LIN AJ, Wright JD, Dehdashti F, Siegel BA, et al
    Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with (18)F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.
    Int J Gynecol Cancer. 2019 Aug 30. pii: ijgc-2019-000528.
    Abstract    

    Abstract available

  183. LUCKETT R, Mogowa N, Li HJ, Erlinger A, et al
    Performance of Two-Stage Cervical Cancer Screening With Primary High-Risk Human Papillomavirus Testing in Women Living With Human Immunodeficiency Virus.
    Obstet Gynecol. 2019 Sep 10. doi: 10.1097/AOG.0000000000003496.
    Abstract    

    Abstract available

  184. GRESSEL GM, Turker L, Dioun SM, McGinn AP, et al
    Characterization of Risk Factors and Timing of Venous Thromboembolism in Patients With Uterine Serous Carcinoma.
    Obstet Gynecol. 2018 Oct 5. doi: 10.1097/AOG.0000000000002932.
    Abstract    

    Abstract available

  185. LIU Z, Zhu W, Kong X, Chen X, et al
    Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer.
    Oncol Rep. 2019 Aug 27. doi: 10.3892/or.2019.7294.
    Abstract    

    Abstract available

  186. PAPPA KI, Lygirou V, Kontostathi G, Makridakis M, et al
    High resolution analysis of the intracellular proteome of cervical cancer cell lines unveils novel regulators of cervical carcinogenesis.
    Oncol Rep. 2019 Aug 8. doi: 10.3892/or.2019.7269.
    Abstract    

    Abstract available

  187. CAO P, Wang Y, Lv Y, Jiang N, et al
    PI3K p110alpha inhibition sensitizes cervical cancer cells with aberrant PI3K signaling activation to PARP inhibitor BMN673.
    Oncol Rep. 2019 Sep 13. doi: 10.3892/or.2019.7313.
    Abstract    

    Abstract available

  188. WU Z, Li J, Zhang Y, Hu L, et al
    Synchronous coexpression of Id1 and nuclear NFkappaB p65 promotes cervical cancer progression and malignancy, and is associated with a poor prognosis and chemosensitivity.
    Oncol Rep. 2019 Sep 5. doi: 10.3892/or.2019.7301.
    Abstract    

    Abstract available

  189. MAHANTSHETTY U, Sturdza A, Naga Ch P, Berger D, et al
    Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Radiother Oncol. 2019 Sep 5. pii: S0167-8140(19)33043.
    Abstract    

    Abstract available

  190. MAPANGA W, Girdler-Brown B, Singh E
    Knowledge, attitudes and practices of young people in Zimbabwe on cervical cancer and HPV, current screening methods and vaccination.
    BMC Cancer. 2019;19:845.
    Abstract    

    Abstract available

  191. SIDORKIEWICZ I, Zbucka-Kretowska M, Zareba K, Lubowicka E, et al
    Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    BMC Cancer. 2019;19:398.
    Abstract    

    Abstract available

  192. CHEN CP, Kung PT, Wang YH, Tsai WC, et al
    Effect of time interval from diagnosis to treatment for cervical cancer on survival: A nationwide cohort study.
    PLoS One. 2019;14:e0221946.
    Abstract    

    Abstract available

  193. DREYER G, Maske C, Stander M
    Clinical evaluation and budget impact analysis of cervical cancer screening using cobas 4800 HPV screening technology in the public sector of South Africa.
    PLoS One. 2019;14:e0221495.
    Abstract    

    Abstract available

  194. PAGE CM, Ibrahim S, Park LP, Huchko MJ, et al
    Patient factors affecting successful linkage to treatment in a cervical cancer prevention program in Kenya: A prospective cohort study.
    PLoS One. 2019;14:e0222750.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;